| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 78.29B | 105.60B | 76.15B | 66.88B | 61.49B | 63.65B |
| Gross Profit | 70.55B | 90.95B | 70.97B | 65.67B | 62.99B | 60.02B |
| EBITDA | 15.94B | 28.80B | 22.24B | 18.91B | 18.63B | 19.80B |
| Net Income | 11.45B | 15.91B | 12.76B | 10.88B | 10.39B | 11.19B |
Balance Sheet | ||||||
| Total Assets | 6.60T | 6.65T | 6.56T | 6.55T | 6.58T | 6.90T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 874.63B | 917.71B | 1.05T | 1.23T | 1.72T |
| Total Debt | 664.14B | 661.15B | 685.98B | 737.66B | 495.90B | 2.73T |
| Total Liabilities | 6.28T | 6.32T | 6.25T | 6.22T | 6.28T | 6.61T |
| Stockholders Equity | 311.99B | 323.99B | 303.98B | 322.75B | 290.54B | 290.77B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.60B | 29.78B | 1.84B | -517.96B | 1.33T |
| Operating Cash Flow | 0.00 | 5.15B | 32.08B | -181.72B | -510.17B | 1.33T |
| Investing Cash Flow | 0.00 | -263.07B | -232.97B | -1.38B | 26.68B | -118.57B |
| Financing Cash Flow | 0.00 | 209.60B | 72.00B | -4.35B | -3.72B | -4.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ¥289.11B | 11.25 | 7.61% | 3.81% | 17.66% | 24.57% | |
70 Outperform | ¥331.33B | 13.05 | ― | 2.27% | 26.67% | 31.83% | |
69 Neutral | ¥287.33B | 12.97 | ― | 3.46% | 11.64% | 26.63% | |
68 Neutral | ¥287.48B | 15.26 | ― | 2.13% | 15.39% | 26.92% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | ¥291.65B | 12.58 | ― | 2.55% | 18.30% | 38.04% | |
55 Neutral | ¥239.00B | -94.53 | ― | 2.38% | 33.44% | 57.44% |